Glenmark to initiate novel drug for cancer
Glenmark Pharmaceuticals SA (GPSA), a wholly owned subsidiary of Glenmark Pharmaceuticals India, has announced the discovery and initiation of investigational new drug enabling studies for […]
Pharmaceuticals
Mylan Pharma launches Harvoni tablet for Hepatisis C
Mylan Pharma has launched generic Harvoni tablets, used to treat Hepatitis C, under the brand name ‘MyHep LVIR’ in India. The drug is an important […]
Torrent Pharma launches Adalimumab in India under the brand “Adfrar”
Torrent Pharmaceuticals has launched bio similar Adalimumab, used for the treatment of auto immune disorders in India its under the brand name ‘Adfrar’. The company’s […]
Aurobindo Pharma receives approval for Norethindrone Acetate t
Aurobindo Pharma Ltd has received approval from the USFDA to manufacture and market Norethindrone Acetate tablets in USA. The approved Abbreviated New Drug Application (ANDA) […]
Aurobindo Pharma to set up manufacturing facility in Saudi Arabia
Aurobindo Pharma is planning to set up a pharma plant in Phase one of the King Abdullah Economic City’s (KAEC) Industrial Valley in Saudi Arabia. […]
Reliance Life Science receives USFDA approval for its Navi Mumbai facility
Reliance Life Sciences has received approval from the USFDA for its active pharmaceutical ingredient (API) manufacturing facility located at Dhirubhai Ambani Life Sciences Centre in […]
Zydus Cadilat to launch breast cancer drug Vivitra
Zydus Cadila has introduced a breast cancer drug in India, a copy of Swiss giant Roche’s product Herceptin. The company selling a version of trastuzumab […]
Indian government plans pharma technology upgradation fund for Rs. 5000 million
India is planning to set up a Rs 500-crore pharma technology upgradation fund which will facilitate cheaper loans to entities looking to upgrade their manufacturing […]
Astrazeneca Pharma shuts down Bangalore unit
AstraZeneca Pharma India (AZPIL) the subsidiary of British-Swedish multinational pharmaceutical and biologics company AstraZeneca, has shut down its Active Pharmaceutical Ingredient (API) unit in Bengaluru. […]
Jubilant Life Sciences recieves approval for anti-depressant Paxil
Jubilant Life Sciences Ltd has received final approval from USFDA for its generic version of anti-depressant Paxil tablets. The final approval for the abbreviated new […]